Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,474 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Genomics
477 cohorts mapped to this entity or its descendants. Each frequency is affected / profiled within one cohort; cohorts are shown separately because case selection, sequencing depth and definitions differ. By default the cohort with the most cases profiled is shown.
119 cases with simple somatic mutation data · 119 cases total · 2026-01-16 · mapped to Renal Pelvis and Ureter Urothelial Carcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 |
Cohorts mapped to a descendant (e.g. a subtype) are included because their cases belong to this entity by definition; the mapping and its match type are shown per cohort.
| Ssm |
| 55 |
| 119 |
| 46.2% |
| cbioportal |
| 2 | KMT2D | Ssm | 41 | 119 | 34.5% | cbioportal |
| 3 | KDM6A | Ssm | 39 | 119 | 32.8% | cbioportal |
| 4 | TERT | Ssm | 32 | 119 | 26.9% | cbioportal |
| 5 | KMT2C | Ssm | 27 | 119 | 22.7% | cbioportal |
| 7 | TP53 | Ssm | 26 | 119 | 21.8% | cbioportal |
| 6 | ARID1A | Ssm | 26 | 119 | 21.8% | cbioportal |
| 8 | STAG2 | Ssm | 24 | 119 | 20.2% | cbioportal |
| 9 | CREBBP | Ssm | 21 | 119 | 17.6% | cbioportal |
| 10 | ATM | Ssm | 19 | 119 | 16% | cbioportal |
| 11 | PIK3CA | Ssm | 19 | 119 | 16% | cbioportal |
| 12 | TSC1 | Ssm | 16 | 119 | 13.4% | cbioportal |
| 13 | HRAS | Ssm | 14 | 119 | 11.8% | cbioportal |
| 45 | ZFHX3 | Ssm | 7 | 60 | 11.7% | cbioportal |
| 14 | SMARCA4 | Ssm | 13 | 119 | 10.9% | cbioportal |
| 18 | FAT1 | Ssm | 11 | 119 | 9.2% | cbioportal |
| 15 | ARID1B | Ssm | 11 | 119 | 9.2% | cbioportal |
| 19 | FBXW7 | Ssm | 11 | 119 | 9.2% | cbioportal |
| 17 | ERBB2 | Ssm | 11 | 119 | 9.2% | cbioportal |
| 16 | EP300 | Ssm | 11 | 119 | 9.2% | cbioportal |
| 20 | NF1 | Ssm | 10 | 119 | 8.4% | cbioportal |
| 21 | PBRM1 | Ssm | 10 | 119 | 8.4% | cbioportal |
| 81 | SPEN | Ssm | 5 | 61 | 8.2% | cbioportal |
| 22 | CDKN1A | Ssm | 9 | 119 | 7.6% | cbioportal |
| 24 | MET | Ssm | 9 | 119 | 7.6% | cbioportal |
| 23 | EPHA5 | Ssm | 9 | 119 | 7.6% | cbioportal |
| 25 | MTOR | Ssm | 9 | 119 | 7.6% | cbioportal |
| 30 | MED12 | Ssm | 8 | 119 | 6.7% | cbioportal |
| 31 | MSH2 | Ssm | 8 | 119 | 6.7% | cbioportal |
| 28 | CTCF | Ssm | 8 | 119 | 6.7% | cbioportal |
Data updated 21 days agoSource updated 2026-01-16